OGN

#1922
Organon & Co.
8.5450 USD
+1.42%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
8.4000
8.5761
Faixa anual
5.6900
9.9400
Mudança diária
+1.42%
Mudança mensal
+33.31%
Mudança em 6 meses
+17.70%
Mudança anual
+17.70%
Fechamento anterior
8.4250
Abrir
8.4050
Bid
Ask
Mínimo
8.4000
High
8.5761
Volume
462
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
  • Market Capitalization 2.2244 B
  • Employee 10 K
  • Founded N/A
  • CEO N/A
  • Website www.organon.com
  • Headquarter New Jersey, United States
  • FIGI BBG00ZQRGW24
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
9.96
Price to sales ratio
0.3
Dividends per share
0.34
Dividend yield %
4.74

Organon & Co

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

Notícias